Literature DB >> 33603039

Peripheral BDNF and psycho-behavioral aspects are positively modulated by high-intensity intermittent exercise and fitness in healthy women.

Rodrigo Araujo Bonetti de Poli1, Vithor Hugo Fialho Lopes1, Fábio Santos Lira2, Alessandro Moura Zagatto1, Alberto Jimenez-Maldonado3, Barbara Moura Antunes4,5.   

Abstract

Acute high-intensity intermittent exercise (HIIE) induces the myokine secretion associated with neurogenesis, as well brain-derived neurotrophic factor (BDNF); however, it remains unknown how the menstrual phase influences this secretion after an acute exercise session. The current study aimed to investigate the effects of HIIE performed in luteal and follicular menstrual phases on BDNF, cognitive function, mood, and exercise enjoyment. Fourteen healthy women completed four experimental sessions, randomly. One graded exercise test (GXT) and one HIIE session (10 × 1-min runs 90% peak GXT velocity [1-min recovery]) were performed for each menstrual phase. Blood samples were collected at rest and immediately after efforts, and the profile of mood states questionnaire (POMS) and Stroop-task test were applied. During the HIIE, subjective scales were applied (feeling, felt arousal, rate of perceived exertion, and physical activity enjoyment). The main results showed that the serum BDNF presented no difference between menstrual phases (p = 0.870); however, HIIE increased BDNF concentration in both menstrual phases (p = 0.030). In addition, the magnitude of circulating BDNF variation (Δ%BDNF) and [Formula: see text] demonstrated an inverse relationship in the follicular phase (r =  - 0.539, p = 0.046), whereas in the luteal phase, Δ%BDNF was negatively correlated with time test (r =  - 0.684, p = 0.007) and RPE (r =  - 0.726, p = 0.004) in GXT. No differences between menstrual phases were observed for POMS (p ≥ 0.05); however, HIIE attenuated tension (p < 0.01), depression (p < 0.01), and anger moods (p < 0.01), independently of menstrual phases. The subjective scales and Stroop-task test did not show differences. In conclusion, menstrual cycle phase does not affect serum BDNF levels, cognitive function, mood, and exercise enjoyment. Contrary, HIIE increases peripheral BDNF and attenuates tension, depression, and anger independently of menstrual phase. In addition, Δ%BDNF was correlated with physical fitness in the follicular phase, exhibiting higher changes in women with lower physical fitness status.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33603039      PMCID: PMC7893166          DOI: 10.1038/s41598-021-83072-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

1.  Cyclic changes in the concentrations of peripheral blood immune cells during the normal menstrual cycle.

Authors:  A L Northern; S M Rutter; C M Peterson
Journal:  Proc Soc Exp Biol Med       Date:  1994-10

2.  The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range.

Authors:  Wim Van der Elst; Martin P J Van Boxtel; Gerard J P Van Breukelen; Jelle Jolles
Journal:  Assessment       Date:  2006-03

3.  Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.

Authors:  A Steensberg; G van Hall; T Osada; M Sacchetti; B Saltin; B Klarlund Pedersen
Journal:  J Physiol       Date:  2000-11-15       Impact factor: 5.182

Review 4.  BDNF mediates adaptive brain and body responses to energetic challenges.

Authors:  Krisztina Marosi; Mark P Mattson
Journal:  Trends Endocrinol Metab       Date:  2013-12-19       Impact factor: 12.015

Review 5.  Physical activity and muscle-brain crosstalk.

Authors:  Bente Klarlund Pedersen
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

Review 6.  Physiological and health-related adaptations to low-volume interval training: influences of nutrition and sex.

Authors:  Martin J Gibala; Jenna B Gillen; Michael E Percival
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

7.  Inflammatory Cytokines and BDNF Response to High-Intensity Intermittent Exercise: Effect the Exercise Volume.

Authors:  Carolina Cabral-Santos; Carlos I M Castrillón; Rodolfo A T Miranda; Paula A Monteiro; Daniela S Inoue; Eduardo Z Campos; Peter Hofmann; Fábio S Lira
Journal:  Front Physiol       Date:  2016-11-04       Impact factor: 4.566

8.  Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise.

Authors:  Asghar Abbasi; Rodolfo de Paula Vieira; Felix Bischof; Michael Walter; Masoud Movassaghi; Nicole C Berchtold; Andreas M Niess; Carl W Cotman; Hinnak Northoff
Journal:  J Neuroinflammation       Date:  2016-11-10       Impact factor: 8.322

Review 9.  Running from Disease: Molecular Mechanisms Associating Dopamine and Leptin Signaling in the Brain with Physical Inactivity, Obesity, and Type 2 Diabetes.

Authors:  Gregory N Ruegsegger; Frank W Booth
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-23       Impact factor: 5.555

Review 10.  The Maximal Oxygen Uptake Verification Phase: a Light at the End of the Tunnel?

Authors:  Gustavo Z Schaun
Journal:  Sports Med Open       Date:  2017-12-08
View more
  2 in total

1.  Menstrual cycle impacts adipokine and lipoprotein responses to acute high-intensity intermittent exercise bout.

Authors:  Tiago Olean-Oliveira; Caique Figueiredo; Rodrigo Araújo Bonetti de Poli; Vithor Hugo Fialho Lopes; Alberto Jimenez-Maldonado; Fábio Santos Lira; Barbara Moura Antunes
Journal:  Eur J Appl Physiol       Date:  2021-09-26       Impact factor: 3.078

2.  Moderate Aerobic Exercise Regulates Follicular Dysfunction by Initiating Brain-Derived Neurotrophic Factor (BDNF)-Mediated Anti-Apoptotic Signaling Pathways in Polycystic Ovary Syndrome.

Authors:  Yaling Zhang; Dejian Chen; Daojuan Wang; Lei Wang; Yajing Weng; Hongwei Wang; Xiaoke Wu; Yong Wang
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.